Tuberculosis chemotherapy in the 21st century: Back to the basics
Open Access
- 1 July 2011
- journal article
- review article
- Published by Wolters Kluwer Health in Lung India
- Vol. 28 (3) , 193-200
Abstract
The key to successful elimination of tuberculosis (TB) is treatment of cases with optimum chemotherapy. Poor chemotherapy over time has led to drug-resistant disease. Drug resistance of Mycobacterium tuberculosis develops by the selective growth of resistant mutants. The incidence of drug-resistant cases depends on the number of bacilli and the drug-resistant mutants in the lesion. The latter is low for individual drugs and even lower for two and three drugs. Therefore, use of combination chemotherapy with three or more drugs results in cure. However, irregular treatment, inadequate drugs, inadequate drug doses or addition of a single drug to a failing regimen allows selective growth of resistant mutants and acquired drug-resistant TB. Contacts of these resistant cases develop primary drug resistant TB. Thus, drug resistance in tuberculosis is a “man-made problem”. Anti-TB chemotherapy must be given optimally by (i) ensuring adequate absorption of drugs, (ii) timely diagnosis and management of drug toxicities and (iii) treatment adherence. New classes of anti-TB drugs are needed; but are unlikely to become available soon. It is vital that the 21st century physicians understand the basic principles of TB chemotherapy to ensure efficient use of available drugs to postpone or even reverse epidemics drug-resistant TB.Keywords
This publication has 47 references indexed in Scilit:
- New drugs and new regimens for the treatment of tuberculosis: review of the drug development pipeline and implications for national programmesCurrent Opinion in Pulmonary Medicine, 2010
- Standardized Treatment of Active Tuberculosis in Patients with Previous Treatment and/or with Mono-resistance to Isoniazid: A Systematic Review and Meta-analysisPLOS Medicine, 2009
- Emergence of New Forms of Totally Drug-Resistant Tuberculosis BacilliChest, 2009
- Doomsday postponed? Preventing and reversing epidemics of drug-resistant tuberculosisNature Reviews Microbiology, 2009
- Paradoxical reactions during tuberculosis treatment in patients with and without HIV co-infectionThorax, 2004
- Drug resistant tuberculosis: back to sanatoria, surgery and cod-liver oil?European Respiratory Journal, 1995
- Treatment of Multidrug-Resistant TuberculosisNew England Journal of Medicine, 1993
- Antituberculous AgentsMayo Clinic Proceedings, 1992
- The treatment of superficial tuberculous lymphadenitisTubercle, 1990
- Dietary constituents and rifampicin absorptionTubercle, 1987